News

EXCITING NEWS

Featured Articles

December 10, 2024

Eikonizo Therapeutics Announces Investment by Novo Nordisk; Advancing Lead Candidate EKZ-102 Toward Clinical Development

July 08, 2020

Eikonizo Therapeutics Announces Publication of the First-in-Human Study of [18F]EKZ-001 and Expansion of Leadership Team, Adding Extensive Experience in Preclinical and Clinical Development

August 12, 2020

Meet the 21 biotech startups that top VCs say are poised to take off in the next 12 months (Subscription Required)

July 08, 2020

Eikonizo Therapeutics Announces Publication of the First-in-Human Study of [18F]EKZ-001 and Expansion of Leadership Team, Adding Extensive Experience in Preclinical and Clinical Development

June 25, 2020

Episode 59: Using Tau to Target Alzheimer’s

June 25, 2020

Episode 59: Using Tau to Target Alzheimer’s

June 2, 2020

UNDER THE MICROSCOPE: LUDO VAN DEN BOSCH ON RETURNING TO WORK, EXPLORING THERAPEUTIC STRATEGIES TO BATTLE ALS & FTD

May 5, 2020

TARGET ALS AND AFTD ANNOUNCE $5MM IN GRANTS FOR RESEARCH TARGETING TREATMENTS AND BIOMARKERS

June 2, 2020

UNDER THE MICROSCOPE: LUDO VAN DEN BOSCH ON RETURNING TO WORK, EXPLORING THERAPEUTIC STRATEGIES TO BATTLE ALS & FTD

May 5, 2020

TARGET ALS AND AFTD ANNOUNCE $5MM IN GRANTS FOR RESEARCH TARGETING TREATMENTS AND BIOMARKERS

Earlier Articles

March 20, 2020

Eikonizo: brain-penetrant HDAC inhibitors for neurodegeneration (Subscription Required)

March 4, 2020

Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer's And Other Dementia

March 20, 2020

Eikonizo: brain-penetrant HDAC inhibitors for neurodegeneration(Subscription Required)

March 4, 2020

Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer's And Other Dementia

September 24, 2019

Dementia-Treatment Startup Seeks to Overcome Prior Drugs’ Failures (Subscription Required)

September 24, 2019

Dementia-Treatment Startup Seeks to Overcome Prior Drugs’ Failures (Subscription Required)